“They’ve been having a run on Ozempic because people don’t want to spend that much on Wegovy,” Schondelmeyer said. Schondelmeyer noted the per-milligram price for Wegovy can be more than twice as much as Ozempic. The same medication, semaglutide, is sold under a different brand name, Wegovy, for weight loss. Pricing might also be a factor with some drugs. Federal regulators limit supplies for the drug each year because it is a controlled substance. Prescriptions for Adderall and its generic equivalents jumped 20% between February 2020 and the end of last year, according to IQVIA.Īdderall supplies face an additional challenge when demand spikes.
The Adderall manufacturing problem hit as more people started taking the drug.ĭuring the pandemic, prescriptions climbed as regulators started allowing doctors to prescribe the drug without first seeing a patient in person. Reasons can vary, and a combination of factors fuels many shortages. Gary Peters, D-Mich., chairman of the Senate Committee on Homeland Security and Governmental Affairs. Injectable drugs used in hospitals and clinics, such as IV saline and some cancer treatments, are more than twice as likely as tablets or topical treatments to experience a shortage, according to a recent report written by Sen. A shortage of the antibiotic amoxicillin also cropped up around then. Last year, a spike in respiratory illnesses forced drugstore chains to temporarily limit purchases of fever-reducing medicines for children. Prescriptions for Ozempic - touted by celebrities and others on social media - have doubled since the summer of 2021 to more than 1.2 million, according to the health data firm IQVIA.Ī spokeswoman for Ozempic maker Novo Nordisk says all doses of the drug are now available at pharmacies nationwide. The FDA also has tracked a shortage of the diabetes treatment Ozempic, which doctors also prescribe for weight loss. But several extended-release doses of the medication, its most popular form, remain in short supply. That situation seems to be improving, said University of Utah Health researcher Erin Fox. That has persisted and grown at times to include other stimulants that treat the condition. Food and Drug Administration announced a shortage of the attention deficit/hyperactivity disorder treatment Adderall due to a manufacturing problem. “But there are more shortages now, and they’re becoming more visible,” he said. Patients don’t feel all drug shortages because doctors may be able to substitute different medications or because other parts of the drug supply system mask the issue, said Stephen Schondelmeyer, a University of Minnesota College of Pharmacy professor.
0 kommentar(er)
